These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35418794)

  • 1. The Use of SGLT-2 Inhibitors Coupled With a Strict Low-Carbohydrate Diet: A Set-Up for Inducing Severe Diabetic Ketoacidosis.
    Guirguis H; Beroukhim Afrahimi S; Pham C
    Clin Med Insights Case Rep; 2022; 15():11795476221090045. PubMed ID: 35418794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
    Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
    Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review.
    Mahfooz RS; Khan MK; Al Hennawi H; Khedr A
    Cureus; 2022 Jun; 14(6):e26267. PubMed ID: 35911365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Euglycemic Diabetic Ketoacidosis in Concurrent Very Low-carbohydrate Diet and Sodium-glucose Transporter-2 Inhibitor Use: A Case Report.
    Earle M; Ault B; Bonney C
    Clin Pract Cases Emerg Med; 2020 May; 4(2):185-188. PubMed ID: 32426668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canagliflozin-Induced Diabetic Ketoacidosis: Case Report and Review of the Literature.
    Turner J; Begum T; Smalligan RD
    J Investig Med High Impact Case Rep; 2016; 4(3):2324709616663231. PubMed ID: 27635409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin.
    Candelario N; Wykretowicz J
    Oxf Med Case Reports; 2016 Jul; 2016(7):144-6. PubMed ID: 27471597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
    Burke KR; Schumacher CA; Harpe SE
    Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-Operative Euglycemic Diabetic Ketoacidosis in a Patient With SGLT-2 Inhibitor Use and Recent Sleeve Gastrectomy.
    Smith A; Holtrop J; Sadoun M
    Cureus; 2021 Apr; 13(4):e14297. PubMed ID: 33968511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misleading Presentation: Chest Pain Masking Euglycemic Diabetic Ketoacidosis Possibly Induced by Empagliflozin.
    Tiwari K; Sharma NR; Pokhrel M; Basnet A; Kaplan M
    Cureus; 2023 Nov; 15(11):e49402. PubMed ID: 38149142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium-Glucose Linked Transporter Inhibitors as a Cause of Euglycemic Diabetic Ketoacidosis on a Background of Starvation.
    Tauseef A; Asghar MS; Zafar M; Lateef N; Thirumalareddy J
    Cureus; 2020 Aug; 12(8):e10078. PubMed ID: 33005504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemic, high anion-gap metabolic acidosis in patients receiving SGLT-2 inhibitors for diabetes management.
    Kum-Nji JS; Gosmanov AR; Steinberg H; Dagogo-Jack S
    J Diabetes Complications; 2017 Mar; 31(3):611-614. PubMed ID: 27913012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol.
    Goldenberg RM; Gilbert JD; Hramiak IM; Woo VC; Zinman B
    Diabetes Obes Metab; 2019 Oct; 21(10):2192-2202. PubMed ID: 31183975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip.
    Zughaib MT; Patel K; Leka M; Affas S
    Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative Euglycemic Ketoacidosis in Type 2 Diabetes Associated with Sodium-Glucose Cotransporter 2 Inhibitor: Insights Into Pathogenesis and Management Strategy.
    Chandrakumar HP; Chillumuntala S; Singh G; McFarlane SI
    Cureus; 2021 Jun; 13(6):e15533. PubMed ID: 34123681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Precipitating Euglycaemic Diabetic Ketoacidosis with SGLT2 Inhibitor Use.
    Fang J; Genco M; Caskey RN
    Eur J Case Rep Intern Med; 2020; 7(11):001943. PubMed ID: 33194873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged diabetic ketoacidosis associated with canagliflozin.
    Sloan G; Kakoudaki T; Ranjan N
    Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 29899991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study.
    Douros A; Lix LM; Fralick M; Dell'Aniello S; Shah BR; Ronksley PE; Tremblay É; Hu N; Alessi-Severini S; Fisher A; Bugden SC; Ernst P; Filion KB;
    Ann Intern Med; 2020 Sep; 173(6):417-425. PubMed ID: 32716707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report].
    Yamamoto M; Ide N; Kitajima S; Obayashi M; Asada K; Matsushima S; Ito M
    Yakugaku Zasshi; 2019; 139(11):1479-1483. PubMed ID: 31685745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors.
    Fukuyama Y; Numata K; Yoshino K; Santanda T; Funakoshi H
    Acute Med Surg; 2020; 7(1):e480. PubMed ID: 31988792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-Onset Euglycemic Diabetic Ketoacidosis in a Patient With Massive Stroke Requiring Decompressive Craniectomy: A Case Report.
    Hussaini SA; Aziz A; Musa M; Alamin M; Danjuma M
    Cureus; 2021 Oct; 13(10):e18629. PubMed ID: 34765377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.